ArticleApplied microbiology and biotechnology2025
3C protease-independent production of foot-and-mouth disease virus-like particles in Pichia pastoris.
Article in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glycosylated Foot-And-Mouth Disease Virus-Like Particles Produced in Pichia Pastoris Enhance Stability and Immunogenicity.Microbial biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The inactivated vaccines have played a pivotal role in the control and eradication of foot-and-mouth disease (FMD). However, certain safety concerns remain. Recently, virus-like particles (VLPs) have gradually become a research hotspot. As the eukaryotic expression system with the lowest production costs, the production of VLPs using Pichia pastoris has significant potential. During the natural infection process of FMD virus (FMDV), the polyprotein P1 is cleaved by 3C protease to form VP0, VP3, and VP1, which are subsequently assembled into VLPs. In this study, we adopted an alternative approach, co-expressing VP0, VP3, and VP1 without 3C protease for the production of FMDV VLPs in P. pastoris. The western blot (WB) assays showed variable protein expression on the same plasmid. VP0 was the highest, while VP3 and VP1 were similar. Furthermore, the order of proteins on the plasmid also mattered. The results indicated that His
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.